KRAS and pancreatic intraductal papillary-mucinous neoplasm: As a pivotal initiator of exocrine tumorigenesis, the Kras gene has been shown through multiple investigations to harbor mutations in the majority of low-grade pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN) lesions.